# The Role of CALLY and HAALP in Ulcerative Colitis

> **NCT07236333** · — · COMPLETED · sponsor: **Ataturk University** · enrollment: 100 (actual)

## Conditions studied

- Ulcerative Colitis (UC)

## Interventions

- **DIAGNOSTIC_TEST:** CALLY
- **DIAGNOSTIC_TEST:** HALP

## Key facts

- **NCT ID:** NCT07236333
- **Lead sponsor:** Ataturk University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07236333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07236333, "The Role of CALLY and HAALP in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07236333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*